Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

A Study of DS-6000a in Subjects With Advanced Renal Cell Carcinoma and Ovarian Tumors

NCT04707248

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +24 more
Locations: Arizona Oncology Associates, PC HOPE (A)A HOPE) Tucson, Arizona, United States

Rocky Mountain Cancer Center Denver, Colorado, United States

Florida Cancer Lake Mary Lake Mary, Florida, United States

Oklahoma University Oklahoma City, Oklahoma, United States

View all 13 locations

View Trial Details

Active, Not Recruiting

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

NCT04522323

Conditions: Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +15 more
Locations: Research Site Washington D.C., District of Columbia, United States

Research Site Fort Myers, Florida, United States

Research Site St Louis, Missouri, United States

Research Site New York, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

NCT05540899

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +10 more
Locations: Milton S. Hershey Medical Center Hershey, Pennsylvania, United States

View Trial Details

Active, Not Recruiting

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

NCT05604560

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
Locations: Johns Hopkins SKCCC Baltimore, Maryland, United States

The University of Texas Health Science Center San Antonio San Antonio, Texas, United States

View Trial Details

Active, Not Recruiting

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

NCT06020885

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Sun yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer

NCT07074535

Conditions: Carcinoma, Carcinoma, Squamous Cell, Cranial Nerve Diseases, +29 more
Locations: Daping Hospital Chongqing, China

View Trial Details

Active, Not Recruiting

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

NCT06248528

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China Wuhan, Hubei, China

View Trial Details

Active, Not Recruiting

PD-1 Blockade Combined With De-intensified Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

NCT04907370

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

First People's Hospital of Foshan Foshan, Guangdong, China

Panyu central hospital Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Hepatocellular Carcinoma Imaging Using PSMA PET/CT

NCT05095519

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: St Vincent's Hospital Fitzroy, Victoria, Australia

Austin Health Heidelberg, Victoria, Australia

Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

The Royal Melbourne Hospital Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy

NCT07065786

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Zhongda hospital Changzhou, Jiangsu, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions